Fine particulate matter — particles smaller than 2.5 microns (PM2.5) — is one of the most comprehensively studied environmental health hazards. Its ability to penetrate deep into the respiratory system and enter the bloodstream makes it uniquely dangerous compared to larger particles.
The biological mechanism linking PM2.5 to cardiovascular disease operates through several pathways: inflammatory response in lung tissue, oxidative stress from reactive oxygen species, direct translocation of ultrafine particles into the bloodstream, and autonomic nervous system dysregulation affecting heart rate variability.
Long-term studies published in peer-reviewed journals have established associations between chronic PM2.5 exposure and increased incidence of ischemic heart disease, stroke, cardiac arrhythmia and heart failure. The Global Burden of Disease study identifies PM2.5 as a major risk factor for cardiovascular mortality worldwide.
For indoor environments, reducing PM2.5 exposure through effective HEPA filtration is one of the most evidence-based interventions available. A well-maintained True HEPA purifier running continuously in a bedroom — where we spend approximately one-third of our lives — represents a meaningful reduction in cumulative PM2.5 exposure.
